Stay updated with breaking news from General Brigham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BRILLIANCE trial results showed 11 out of 14 treated participants experienced some improvements in vision and quality of life measures. CRISPR-based therapy
Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.
Mammograms and early detection save lives, but delays persist since the pandemic and there's hope Boston's medical community can catch up on early screening appointments.
A new study from Mass General Brigham has found that large foundation models that incorporate a richer level of details may mitigate disparities between different demographic groups and enhance model security. Corresponding author Faisal Mahmood, PhD, of the Division of Computational Pathology in the Department of Pathology at Mass General Brigham referred to the findings as a "call to action" for scientists and regulators to utilize diverse data sets in research to benefit all patient groups. Find details in the news story below.
Discover how hospitals and health systems are responding to the increasing cost of long-term debt and creating growth opportunities through M&A.